CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-12 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2019-12-12 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2019-12-12 | Hunt Daniel W. SVP, Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-12-12 | Buggy Joseph J EVP, Discovery Research | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-11-13 | MILLER RICHARD A MD President and CEO | Purchase | +14,736 | $3.00 | $44K | 1,178,515 |
| 2019-11-12 | MILLER RICHARD A MD President and CEO | Purchase | +272 | $2.90 | $789 | 1,163,779 |
| 2019-08-07 | MILLER RICHARD A MD President and CEO | Purchase | +2,500 | $3.54 | $9K | 1,163,507 |
| 2019-08-06 | Thompson Peter A. Director | Purchase | +142,656 | $3.51 | $501K | 6,767,584 |
| 2019-08-06 | ORBIMED ADVISORS LLC Director | Purchase | +142,656 | $3.51 | $501K | 6,767,584 |
| 2019-08-06 | MILLER RICHARD A MD President and CEO | Purchase | +5,000 | $3.58 | $18K | 1,161,007 |
| 2019-07-25 | Novo Holdings A/S 10% owner | Sale | −1,400,000 | $4.00 | $5.6M | 2,927,560 |
| 2019-07-24 | Novo Holdings A/S 10% owner | Sale | −53,240 | $5.01 | $267K | 4,327,560 |
| 2019-07-23 | Novo Holdings A/S 10% owner | Sale | −39,716 | $5.32 | $211K | 4,380,800 |
| 2019-07-01 | Thompson Peter A. Director | Purchase | +59,243 | $3.91 | $232K | 6,624,928 |
| 2019-07-01 | ORBIMED ADVISORS LLC Director | Purchase | +59,243 | $3.91 | $232K | 6,624,928 |
| 2019-06-28 | Thompson Peter A. Director | Purchase | +565,178 | $3.72 | $2.1M | 6,565,685 |
| 2019-06-28 | ORBIMED ADVISORS LLC Director | Purchase | +565,178 | $3.72 | $2.1M | 6,565,685 |
| 2019-06-27 | Thompson Peter A. Director | Purchase | +32,923 | $3.34 | $110K | 6,000,507 |
| 2019-06-27 | ORBIMED ADVISORS LLC Director | Purchase | +32,923 | $3.34 | $110K | 6,000,507 |
| 2019-06-20 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 10 of 19 · 371 trades